Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast cancer – A retrospective cohort study
Author:
Funder
National Cancer Research Institute
Publisher
Elsevier BV
Subject
General Medicine,Surgery
Reference47 articles.
1. Personalizing the treatment of women with early breast cancer: highlights of the st gallen international expert consensus on the primary therapy of early breast cancer 2013;Goldhirsch;Ann Oncol,2013
2. Treatment of HER2-positive breast cancer: current status and future perspectives;Arteaga;Nat Rev Clin Oncol,2011
3. Untangling the ErbB signalling network;Yarden;Nat Rev Mol Cell Biol,2001
4. Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study;Vici;Breast Canc Res Treat,2014
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. miRNAs as biomarkers breast cancer and their influence on tumor epigenetics;Epigenetics in Human Disease;2024
2. Differential response of HER2-positive breast cancer to anti-HER2 therapy based on HER2 protein expression level;British Journal of Cancer;2023-09-22
3. Circulating microRNAs can predict chemotherapy-induced toxicities in patients being treated for primary breast cancer;Breast Cancer Research and Treatment;2023-08-04
4. Breast cancer: miRNAs monitoring chemoresistance and systemic therapy;Frontiers in Oncology;2023-06-16
5. Heart Failure Association-International Cardio-Oncology Society Risk Score Validation in HER2-Positive Breast Cancer;Journal of Clinical Medicine;2023-02-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3